Comparison of Dihydrotachysterol and 5,6-trans Vitamin D3 on Intestinal Calcium Absorption in Patients with Chronic Renal Failure

1974 ◽  
Vol 52 (2) ◽  
pp. 272-274 ◽  
Author(s):  
R. Gagnon ◽  
G. W. Ogden ◽  
G. Just ◽  
M. Kaye
Keyword(s):  
Vitamin D ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Vitamin D3 ◽  
Calcium Absorption ◽  
Intestinal Calcium Absorption ◽  
Vitamin D Analogue

The effect of dihydrotachysterol2 and of 5,6-trans vitamin D3 on calcium absorption in patients with severe chronic renal failure were compared. Dihydrotachysterol appeared to be more effective than the vitamin D analogue.

The Effect of 25-Hydroxy Vitamin D3 in the Osteomalacia of Chronic Renal Failure

1977 ◽  
Vol 52 (5) ◽  
pp. 499-508 ◽  
Author(s):  
J. B. Eastwood ◽  
T. C. B. Stamp ◽  
H. E. De Wardener ◽  
P. J. Bordier ◽  
C. D. Arnaud
Keyword(s):  
Vitamin D ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Plasma Concentration ◽  
Muscle Strength ◽  
Vitamin D3 ◽  
Calcium Absorption ◽  
Bone Mineralization ◽  
25 Hydroxy Vitamin D ◽  
Substantial Rise

1. Five patients with the osteomalacia of chronic renal failure were given 50–100 nmol of 25-hydroxy vitamin D3 intravenously per day for 24–28 days. 2. In all five patients, during administration of 25-hydroxy vitamin D3 there was a substantial rise in the plasma concentration of 25-hydroxy vitamin D from initially abnormally low values. 3. Significant improvement in bone mineralization, intestinal calcium absorption and muscle strength occurred in the three patients with the greatest rise in plasma 25-hydroxy vitamin D.

scholarly journals Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization

Blood ◽  
1989 ◽  
Vol 74 (1) ◽  
pp. 82-93 ◽  
Author(s):  
JY Zhou ◽  
AW Norman ◽  
M Lubbert ◽  
ED Collins ◽  
MR Uskokovic ◽  
...  
Keyword(s):  
Vitamin D ◽  
Mechanism Of Action ◽  
Vitamin D3 ◽  
Clonal Growth ◽  
Calcium Absorption ◽  
Active Form ◽  
Intestinal Calcium Absorption ◽  
Leukemic Cells ◽  
Binding Studies ◽  
Vitamin D Analogs

Abstract Induction of terminal differentiation of leukemic and preleukemic cells is a therapeutic approach to leukemia and preleukemia. The 1 alpha, 25- dihydroxyvitamin D3 [1,25(OH)2D3], the hormonally active form of vitamin D3, can induce differentiation and inhibit proliferation of leukemia cells, but concentrations required to achieve these effects cause life-threatening hypercalcemia. Seven new analogs of 1,25(OH)2D3 were discovered to be either equivalent or more potent than 1,25(OH)2D3 as assessed by: (a) inhibition of clonal proliferation of HL-60, EM-2, U937, and patients' myeloid leukemic cells: and (b) induction of differentiation of HL-60 promyelocytes. Furthermore, these analogs stimulated clonal growth of normal human myeloid stem cells. The most potent analog, 1,25-dihydroxy-16ene-23yne-vitamin D3, was about fourfold more potent than 1,25(OH)2D3. This analog decreased clonal growth and expression of c-myc oncogene in HL-60 cells by 50% within ten hours of exposure. Effects on calcium metabolism of these novel analogs in vivo was assessed by intestinal calcium absorption (ICA) and bone calcium mobilization (BCM). Each of the analogs mediated markedly less (10 to 200-fold) ICA and BCM as compared with 1,25(OH)2D3. To gain insight into the possible mechanism of action of these new analogs, receptor binding studies were done with 1,25(OH)2–16ene-23yne-D3 and showed that it competed only about 60% as effectively as 1,25(OH)2D3 for 1,25(OH)2D3 receptors present in HL-60 cells and 98% as effective as 1,25(OH)2D3 for receptors present in chick intestinal cells. In summary, we have discovered seven novel vitamin D analogs that are more potent than the physiologic 1,25(OH)2D3 as measured by a variety of hematopoietic assays. In contrast, these compounds appear to have the potential to be markedly less toxic (induction of hypercalcemia). These novel vitamin D compounds may be superior to 1,25(OH)2D3 in a number of clinical situations including leukemia/preleukemia; they will provide a tool to dissect the mechanism of action of vitamin D seco-steroids in promoting cellular differentiation.

scholarly journals Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization

Blood ◽  
1989 ◽  
Vol 74 (1) ◽  
pp. 82-93 ◽  
Author(s):  
JY Zhou ◽  
AW Norman ◽  
M Lubbert ◽  
ED Collins ◽  
MR Uskokovic ◽  
...  
Keyword(s):  
Vitamin D ◽  
Mechanism Of Action ◽  
Vitamin D3 ◽  
Clonal Growth ◽  
Calcium Absorption ◽  
Active Form ◽  
Intestinal Calcium Absorption ◽  
Leukemic Cells ◽  
Binding Studies ◽  
Vitamin D Analogs

Induction of terminal differentiation of leukemic and preleukemic cells is a therapeutic approach to leukemia and preleukemia. The 1 alpha, 25- dihydroxyvitamin D3 [1,25(OH)2D3], the hormonally active form of vitamin D3, can induce differentiation and inhibit proliferation of leukemia cells, but concentrations required to achieve these effects cause life-threatening hypercalcemia. Seven new analogs of 1,25(OH)2D3 were discovered to be either equivalent or more potent than 1,25(OH)2D3 as assessed by: (a) inhibition of clonal proliferation of HL-60, EM-2, U937, and patients' myeloid leukemic cells: and (b) induction of differentiation of HL-60 promyelocytes. Furthermore, these analogs stimulated clonal growth of normal human myeloid stem cells. The most potent analog, 1,25-dihydroxy-16ene-23yne-vitamin D3, was about fourfold more potent than 1,25(OH)2D3. This analog decreased clonal growth and expression of c-myc oncogene in HL-60 cells by 50% within ten hours of exposure. Effects on calcium metabolism of these novel analogs in vivo was assessed by intestinal calcium absorption (ICA) and bone calcium mobilization (BCM). Each of the analogs mediated markedly less (10 to 200-fold) ICA and BCM as compared with 1,25(OH)2D3. To gain insight into the possible mechanism of action of these new analogs, receptor binding studies were done with 1,25(OH)2–16ene-23yne-D3 and showed that it competed only about 60% as effectively as 1,25(OH)2D3 for 1,25(OH)2D3 receptors present in HL-60 cells and 98% as effective as 1,25(OH)2D3 for receptors present in chick intestinal cells. In summary, we have discovered seven novel vitamin D analogs that are more potent than the physiologic 1,25(OH)2D3 as measured by a variety of hematopoietic assays. In contrast, these compounds appear to have the potential to be markedly less toxic (induction of hypercalcemia). These novel vitamin D compounds may be superior to 1,25(OH)2D3 in a number of clinical situations including leukemia/preleukemia; they will provide a tool to dissect the mechanism of action of vitamin D seco-steroids in promoting cellular differentiation.

Effect of vitamin D3 (cholecalciferol) on plasma calcium and intestinal 45calcium absorption in goldfish, Carassius auratus L.

1984 ◽  
Vol 62 (1) ◽  
pp. 34-36 ◽  
Author(s):  
James C. Fenwick
Keyword(s):  
Vitamin D ◽  
Food Deprivation ◽  
Vitamin D3 ◽  
Carassius Auratus ◽  
Calcium Absorption ◽  
Plasma Calcium ◽  
Intestinal Calcium Absorption ◽  
Total Calcium ◽  
Goldfish Carassius Auratus

Goldfish that were fed as well as not fed for 2 weeks had similar plasma total calcium levels, and vitamin D3 injections during the last 6 days had no significant effect on this parameter. When fish were fed for 1 day after 13 days of food deprivation, plasma calcium increased significantly and this increase was augmented by vitamin D3 injections. This latter group also showed a chlorpromazine-sensitive increase in 45calcium absorption from perfused everted gut sacs when compared with the controls. It was concluded that vitamin D3 stimulates intestinal calcium absorption in the goldfish.

Measurement of Oral Calcium Absorption from the Gut by External Isotope Counting

1971 ◽  
Vol 57 (2) ◽  
pp. 88-91
Author(s):  
Murdoch A. Macleod
Keyword(s):  
Vitamin D ◽  
Renal Failure ◽  
Calcium Metabolism ◽  
Calcium Absorption ◽  
Normal Subjects ◽  
Intestinal Calcium Absorption ◽  
Calcium Balance ◽  
Oral Calcium ◽  
Absorption Current ◽  
Reliable Methods

AbstractAmong the factors which regulate normal gastro-intestinal calcium absorption, current thought recognises calcium intake, vitamin D and parathyroid hormone as playing an important part. It is well documented that gastro-intestinal calcium absorption is reduced in states of malabsorption, hypoparathyroidism and in patients with chronic renal failure, and raised in states of hyperparathyroidism, urolithiasis and idiopathic hypercalcuria.Difficulties inherent in classic calcium-balance techniques have prompted a search for more practical and reliable methods of measuring the degree of impairment of calcium absorption. This paper describes a study of intestinal calcium absorption in 10 normal subjects and four patients, with various disorders of calcium metabolism, using an external radio-isotope counting technique.

A longitudinal study of bone-mineral content and intestinal calcium absorption in patients with chronic renal failure

Metabolism ◽  
1979 ◽  
Vol 28 (11) ◽  
pp. 1114-1121 ◽  
Author(s):  
J.R. Juttmann ◽  
J.C.W. Hagenouw-Taal ◽  
L.D.F. Lameyer ◽  
A.M. Ruis ◽  
J.C. Birkenhäger
Keyword(s):  
Renal Failure ◽  
Longitudinal Study ◽  
Chronic Renal Failure ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Mineral Content ◽  
Calcium Absorption ◽  
Intestinal Calcium Absorption
Sign in / Sign up

Export Citation Format

Share Document